-
Pediatr. Infect. Dis. J. · May 2007
Valganciclovir for congenital CMV infection: a pilot study on plasma concentration in newborns and infants.
- Luisa Galli, Andrea Novelli, Elena Chiappini, Paola Gervaso, Maria Iris Cassetta, Stefania Fallani, and Maurizio de Martino.
- Departments of Pediatrics, University of Florence, Florence, Italy.
- Pediatr. Infect. Dis. J. 2007 May 1;26(5):451-3.
AbstractThe pharmacokinetics of valganciclovir were studied in 8 infants ranging in age from 4 to 90 days (mean 20 days). We suggest that doses of 15 mg/kg given twice daily may be suitable for neonates and young infants.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..